Theravance Biopharma buy melinda
Start price
03.08.17
/
50%
€32.04
Target price
26.12.17
€42.00
Performance (%)
-13.61%
End price
26.12.17
€27.68
Summary
This prediction ended on 26.12.17 with a price of €27.68. The price of Theravance Biopharma has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.61%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Theravance Biopharma | -4.698% | -4.698% | -19.774% | -40.833% |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
Comments by melinda for this prediction
In the thread Theravance Biopharma diskutieren
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Theravance Biopharma
Theravance Biopharma
Start price
Target price
Perf. (%)
€22.20
11.03.20
11.03.20
€25.00
21.08.20
21.08.20
-29.73%
21.08.20
21.08.20
Theravance Biopharma
Start price
Target price
Perf. (%)
€25.38
10.02.18
10.02.18
€32.11
13.08.18
13.08.18
-0.43%
13.08.18
13.08.18
Theravance Biopharma
Start price
Target price
Perf. (%)
€28.90
03.08.17
03.08.17
€37.88
26.12.17
26.12.17
-13.61%
26.12.17
26.12.17